Olivia Spleiss
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Transplantation top 5%
Papers in
- Immunology 11
- Immune Response and Inflammation 5
- Immunodeficiency and Autoimmune Disorders 2
-
- Neuroinflammation and Neurodegeneration Mechanisms 5
- Co-authors
- Bernd L. Fiebich (4 shared papers)Michael Hüll (1 shared paper)Erik Boddeke (2 shared papers)Thomas Berger (4 shared papers)Dietrich van Calker (3 shared papers)Stefan Frentzel (1 shared paper)Jeffrey K. Harrison (1 shared paper)Peter J. Gebicke-Härter (1 shared paper)
- Journals
- Blood (2 papers)International Journal of Cancer (2 papers)Genome Medicine (1 paper)Journal of Clinical Oncology (1 paper)Pharmacogenetics and Genomics (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Olivia Spleiss
29 papers receiving 2.5k citations
Olivia Spleiss's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.0k
- Transplantation 77
- Molecular Biology 1.4k
- Neurology 163
- Cancer Research 253
Countries citing papers authored by Olivia Spleiss
This map shows the geographic impact of Olivia Spleiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Spleiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Spleiss more than expected).
Fields of papers citing papers by Olivia Spleiss
This network shows the impact of papers produced by Olivia Spleiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Spleiss. The network helps show where Olivia Spleiss may publish in the future.
Co-authors
The 25 scholars most cited alongside Olivia Spleiss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors Hit paper breakdown → | 2012 | 889 |
| 2 | 2013 | 311 | |
| 3 | 2013 | 183 | |
| 4 | 2014 | 131 | |
| 5 | 2001 | 112 | |
| 6 | 1999 | 109 | |
| 7 | 2008 | 101 | |
| 8 | 2016 | 89 | |
| 9 | 2016 | 77 | |
| 10 | 2010 | 72 | |
| 11 | 2018 | 69 | |
| 12 | 2014 | 54 | |
| 13 | 2010 | 53 | |
| 14 | 1998 | 43 | |
| 15 | 2016 | 39 | |
| 16 | 1998 | 38 | |
| 17 | 2000 | 30 | |
| 18 | 2001 | 29 | |
| 19 | 2011 | 21 | |
| 20 | 2011 | 18 |
About Olivia Spleiss
Olivia Spleiss is a scholar working on Immunology, Neurology, Oncology, Virology and Molecular Biology, having authored 29 papers that have together received 2.5k indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Immune Response and Inflammation (5 papers), Melanoma and MAPK Pathways (4 papers), Chemokine receptors and signaling (3 papers), Computational Drug Discovery Methods (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Oncology (1.0k citations), Transplantation (77 citations), Molecular Biology (1.4k citations), Neurology (163 citations) and Cancer Research (253 citations). Olivia Spleiss has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Bernd L. Fiebich, Michael Hüll, Erik Boddeke, Thomas Berger, Dietrich van Calker, Stefan Frentzel, Jeffrey K. Harrison, Peter J. Gebicke-Härter, Manuel Buttini and Peter J. Gebicke‐Haerter. Their work appears in journals such as Blood, International Journal of Cancer, Genome Medicine, Journal of Clinical Oncology and Pharmacogenetics and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.